Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3
Authors
Fisher, MarcUMass Chan Affiliations
Department of NeurologyDocument Type
Journal ArticlePublication Date
2003-06-01Keywords
Clinical Trials as TopicCombined Modality Therapy
Diagnostic Imaging
*Disease Management
*Health Planning Guidelines
Humans
Neuroprotective Agents
Patient Selection
Research Design
Stroke
Thrombolytic Therapy
Time Factors
Nervous System Diseases
Neurology
Metadata
Show full item recordAbstract
BACKGROUND: The development of acute stroke therapy has proven to be a daunting task, with a few successful and many unsuccessful trials. New strategies need to be considered to enhance the chances for success in future trials. SUMMARY OF REVIEW: The third Stroke Therapy Academic Industry Roundtable (STAIR) conference focused on issues related to increasing the percentage of acute stroke patients who might be included in acute stroke therapy trials and ultimately treated with drugs proven to be effective. A second focus was directed at the need for implementing multimodality stroke trials and potential ways to organize such trials in the near future. Finally, concepts for organizing and implementing acute stroke trials that incorporate current, state of the art trial methodology were discussed. CONCLUSIONS: It is hoped that these suggestions will enhance future stroke trials and the development of effective, new acute stroke treatments that are maximally effective and utilized.Source
Stroke. 2003 Jun;34(6):1539-46. Epub 2003 May 15. Link to article on publisher's siteDOI
10.1161/01.STR.0000072983.64326.53Permanent Link to this Item
http://hdl.handle.net/20.500.14038/37787PubMed ID
12750546Related Resources
Link to article in PubMedae974a485f413a2113503eed53cd6c53
10.1161/01.STR.0000072983.64326.53